BackCheckmate Pharmaceuticals Overview

Checkmate Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for CMPI.

Quarterly EBIT

-$15.85M
↓ 11.76% YoY

As of Mar 31, 2022

Annual EBIT (TTM)

-$63.12M
↓ 46.07% YoY

Trailing 12 months ending Mar 31, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin